Company news

Kuros Biosciences Ltd. news in 2025

Kuros Biosciences Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion

December 2, 2025

Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference

November 26, 2025

Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025

October 16, 2025

Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025

September 30, 2025

Kuros statement on media inquiry concerning former Board member

September 18, 2025

Kuros Biosciences announces changes in the Board of Directors

September 4, 2025

Kuros Biosciences Reports First Half of 2025 Results

August 14, 2025

Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance

August 5, 2025

Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich

May 13, 2025

Annual General Meeting of Kuros Biosciences approves all resolutions

April 15, 2025

Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025

April 15, 2025

Kuros Biosciences grows sales to CHF 75.6 million for 2024

March 11, 2025

Decks in 2025